187 related articles for article (PubMed ID: 29027812)
1. Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study.
Mora P; Buskirk A; Lyden M; Parkin CG; Borsa L; Petersen B
Diabetes Technol Ther; 2017 Dec; 19(12):715-722. PubMed ID: 29027812
[TBL] [Abstract][Full Text] [Related]
2. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
[TBL] [Abstract][Full Text] [Related]
4. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
[TBL] [Abstract][Full Text] [Related]
5. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
6. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ.
Bradley C; Plowright R; Stewart J; Valentine J; Witthaus E
Health Qual Life Outcomes; 2007 Oct; 5():57. PubMed ID: 17927832
[TBL] [Abstract][Full Text] [Related]
7. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
[TBL] [Abstract][Full Text] [Related]
8. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
Cappelleri JC; Cefalu WT; Rosenstock J; Kourides IA; Gerber RA
Clin Ther; 2002 Apr; 24(4):552-64. PubMed ID: 12017400
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
[TBL] [Abstract][Full Text] [Related]
10. Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.
Schnell O; Klausmann G; Gutschek B; Garcia-Verdugo RM; Hummel M
J Diabetes Sci Technol; 2017 Nov; 11(6):1218-1225. PubMed ID: 28443343
[TBL] [Abstract][Full Text] [Related]
11. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
12. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
13. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1.
Kramer G; Michalak L; Müller UA; Kloos C; Werner C; Kuniss N
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):303-308. PubMed ID: 31185506
[TBL] [Abstract][Full Text] [Related]
14. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.
Kulzer B; Daenschel W; Daenschel I; Schramm W; Messinger D; Weissmann J; Vesper I; Parkin CG; Heinemann L
Diabetes Res Clin Pract; 2018 Oct; 144():200-212. PubMed ID: 30205184
[TBL] [Abstract][Full Text] [Related]
15. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study.
Al Hayek AA; Al Dawish MA
Adv Ther; 2022 Apr; 39(4):1582-1595. PubMed ID: 35119622
[TBL] [Abstract][Full Text] [Related]
17. Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin-A Crossover Study.
Gonzalez C; Picón MJ; Tomé M; Pujol I; Fernández-García JC; Chico A
Diabetes Technol Ther; 2016 May; 18(5):282-7. PubMed ID: 26886163
[TBL] [Abstract][Full Text] [Related]
18. Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.
Tsukube S; Ikeda Y; Kadowaki T; Odawara M
Diabetes Ther; 2015 Jun; 6(2):153-71. PubMed ID: 26040914
[TBL] [Abstract][Full Text] [Related]
19. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
20. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Beck RW; Riddlesworth TD; Ruedy K; Ahmann A; Haller S; Kruger D; McGill JB; Polonsky W; Price D; Aronoff S; Aronson R; Toschi E; Kollman C; Bergenstal R;
Ann Intern Med; 2017 Sep; 167(6):365-374. PubMed ID: 28828487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
